Dermal Photonics Corp. in Peabody, Massachusetts was inspected by the Food and Drug Administration (FDA) on July 18 for radiation control and health safety act and received three citations, according to data posted on the FDA’s official website.
The FDA website indicates that the citations were delivered to the company as follows:
‘Procedures for design output have not been established.’
‘The design verification results, including method(s), were not documented in the design history file.’
‘Procedures for design transfer have not been established.’
The FDA routinely inspects facilities across the nation to determine if the workplaces and their products are compliant with FDA-regulated laws and regulations implemented to improve overall public health. Inspection results are then disclosed publicly for businesses to consistently make smarter business decisions for the future.
The FDA is a government agency that is primarily responsible for monitoring the manufacturing and distribution of human and animal drugs, biological products, medical supplies and tobacco products for safety quality, according to its website.
